AAAAAA

   
Results: 1-10 |
Results: 10
re: Long-term survival in patients with early breast cancer and histologically involved internal mammary chain
Authors: Arriagada, R Le, MG Rochard, F Spielmann, M
Citation: R. Arriagada et al., re: Long-term survival in patients with early breast cancer and histologically involved internal mammary chain, BREAST, 10(1), 2001, pp. 85-86
What is going on in cancer epidemiology in 2001?
Authors: Bonaiti-Pellie, C Doyon, F Le, MG
Citation: C. Bonaiti-pellie et al., What is going on in cancer epidemiology in 2001?, M S-MED SCI, 17(5), 2001, pp. 586-595
c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients
Authors: Riou, G Mathieu, MC Barrois, M Le Bihan, ML Ahomadegbe, JC Benard, J Le, MG
Citation: G. Riou et al., c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients, INT J CANC, 95(4), 2001, pp. 266-270
Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality
Authors: Andrieu, N Prevost, T Rohan, TE Luporsi, E Le, MG Gerber, M Zaridze, DG Lifanova, Y Renaud, R Lee, HP Duffy, SW
Citation: N. Andrieu et al., Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality, INT J EPID, 29(2), 2000, pp. 214-223
Adjuvant radiotherapy in breast cancer - The treatment of lymph node areas
Authors: Arriagada, R Le, MG
Citation: R. Arriagada et Mg. Le, Adjuvant radiotherapy in breast cancer - The treatment of lymph node areas, ACTA ONCOL, 39(3), 2000, pp. 295-305
Do internal mammary chain nodes matter in the prognosis of axillary node-negative breast cancer?
Authors: Arriagada, R Guinebretiere, JM Le, MG
Citation: R. Arriagada et al., Do internal mammary chain nodes matter in the prognosis of axillary node-negative breast cancer?, ACTA ONCOL, 39(3), 2000, pp. 307-308
Increased risk of second cancers following breast cancer: Role of the initial treatment
Authors: Rubino, C de Vathaire, F Diallo, I Shamsaldin, A Le, MG
Citation: C. Rubino et al., Increased risk of second cancers following breast cancer: Role of the initial treatment, BREAST CANC, 61(3), 2000, pp. 183-195
Postmastectomy radiotherapy: Randomized trials
Authors: Arriagada, R Rutqvist, LE Le, MG
Citation: R. Arriagada et al., Postmastectomy radiotherapy: Randomized trials, SEM RAD ONC, 9(3), 1999, pp. 275-286
Percutaneous progesterone use and risk of breast cancer: Results from a French cohort study of premenopausal women with benign breast disease
Authors: Plu-Bureau, G Le, MG Thalabard, JC Sitruk-Ware, R Mauvais-Jarvis, P
Citation: G. Plu-bureau et al., Percutaneous progesterone use and risk of breast cancer: Results from a French cohort study of premenopausal women with benign breast disease, CANCER DET, 23(4), 1999, pp. 290-296
c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: Evidence of a link between bcl-2 protein over-expression and a lowerrisk of metastasis and death in operable patients
Authors: Le, MG Mathieu, MC Douc-Rasy, S Le Bihan, ML Abd El All, H Spielmann, M Riou, G
Citation: Mg. Le et al., c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: Evidence of a link between bcl-2 protein over-expression and a lowerrisk of metastasis and death in operable patients, INT J CANC, 84(6), 1999, pp. 562-567
Risultati: 1-10 |